Drug Model Explorer, DMX, Pharsight, Pharsight Knowledgebase Server, PKS, PKS Validation Suite, PKS Reporter, PKS Office Client, WinNonlin, WinNonlin AutoPilot, IVIVC Toolkit for WinNonlin, Trial Simulator and WNL Validation Suite are trademarks or registered trademarks of Pharsight Corporation.
Financial Tables Below
PHARSIGHT CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended Six Months Ended
September 30, September 30,
---------------------- ----------------------
2007 2006 2007 2006
--------- --------- --------- ---------
Revenues:
License $1,520 $1,522 $2,731 $2,740
Renewal 1,795 1,351 3,481 2,640
Maintenance 329 239 619 475
Services 3,685 3,172 6,548 5,857
--------- --------- --------- ---------
Total revenues 7,329 6,284 13,379 11,712
Cost of revenues 2,408 1,817 4,711 3,573
--------- --------- --------- ---------
Gross profit 4,921 4,467 8,668 8,139
Operating expenses:
Research and
development 1,177 1,019 2,367 1,974
Sales and marketing 1,689 1,390 3,278 2,953
General and
'/>"/>
| SOURCE Pharsight Corporation Copyright©2007 PR Newswire. All rights reserved |